# Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia

> **NCT01052389** · PHASE4 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 300 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Olanzapine
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT01052389
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2012-06
- **Final completion:** 2013-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2014-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052389, "Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01052389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*